HighMark Wealth Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
HighMark Wealth Management's APGE Position: Q3 2026 in Review
HighMark Wealth Management sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 32,266 shares — an estimated $4.28M sold.
HighMark Wealth Management first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $4.28M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- HighMark Wealth Management reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- HighMark Wealth Management sold 32,266 Apogee Therapeutics shares in Q3 2026, an estimated $4.28M.
- HighMark Wealth Management first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
- HighMark Wealth Management's Apogee Therapeutics position peaked at $4.28M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.